Hot Products
Hot products from BioCrick which is a professional high-purity natural products manufacturer are well known to scientists around the world because of their high purity and stability. Each product is a chemical compound or substance produced by a living organism—that is, found in nature. In the broadest sense, natural products include any substance produced by life.Natural products remain the best sources of drugs and drug leads, and this remains true today despite the fact that many pharmaceutical companies have deemphasized natural products research in favor of HTP screening of combinatorial libraries during the past 2 decades. From 1940s to date, 131 (74.8%) out of 175 small molecule anticancer drugs are natural product-based/inspired, with 85 (48.6%) being either natural products or derived therefrom. From 1981 to date, 79 (80%) out of 99 small molecule anticancer drugs are natural product-based/inspired, with 53 (53%) being either natural products or derived therefrom. Among the 20 approved small molecule New Chemical Entities (NCEs) in 2010, a half of them are natural products.
Hot products from the professional high-purity natural products manufacturer
| Cat.No. | Product Name |
|---|---|
| BCN3032 | Malvidin-3-O-arabinoside chloride |
| 1. Malvidin-3-O-arabinoside chloride has antioxidant activity . 2. Malvidin-3-O-arabinoside chloride has potential preventive effect in colorectal diseases. | |
| BCN3033 | Ganoderic acid A |
| Ganoderic acid A , a representative active triterpenoid from Ganoderma lucidum, exhibits antinociceptive, antioxidative, cytotoxic, hepatoprotective and anticancer activities. It has a wide spectrum of targets including nuclear transcription factor-kappaB,activator protein-1,STAT,IL-6,JAK, and p38MAPK. | |
| BCN3034 | Ganoderic acid B |
| Ganoderic acid B is a chemical marker in quality control of G. lucidum and related products. Ganoderic acid B-containing herbs has potential influence towards therapeutic window of trifluoperazine.Ganoderic acid B has antinociceptive effect; it is moderately active inhibitors against HIV-1 protease with a 50% inhibitory concentration of 0.17-0.23 mM. | |
| BCN3035 | Ganoderic acid C1 |
| 1. Ganoderic acid C1 inhibits histamine release. 2. Ganoderic acid C1 has anti-tumor-promoting activity. 3. Ganoderic acid C1 is moderately active inhibitors against HIV-1 protease. 4. Ganoderic acid C1 has anti-inflammatory activity, has potential for treating TNF-α mediated inflammation in asthma and other inflammatory diseases. | |
| BCN3036 | Ganoderic acid C2 |
| Ganoderic acid C2 has anti-inflammatory,and anti-tumor-promoting activities. Ganoderic acid C2 can inhibit histamine release, it also has inhibitory effects on the induction of Epstein-Barr Virus early antigen. | |
| BCN3037 | Ganoderic acid F |
| Ganoderic acid F has anti-hepatitis B, anti-inflammatory, and anti-tumor-promoting activities. | |
| BCN3038 | Ganoderic acid H |
| Ganoderic acid H is a potent antitumour agent, it mediates its biological effects through the inhibition of transcription factors AP-1 and NF-kappaB, resulting in the down-regulation of expression of Cdk4. | |
| BCN3039 | Ganoderic acid K |
| 1. Ganoderic acid K has anti-tumor activity. 2. Ganoderic acid K has anti-inflammatory activity. 3. Ganoderic acid K is an angiotensin-converting enzyme inhibitor. | |
